Medical supplies Korean listed companies

Grouped by the industry code each company registered with DART. Sorted by latest quarterly operating profit.

Companies32

Operating profit₩81.8bnlatest quarter, combined

Operating losses15

Average dividend yield2.4%8 payers

There are 32 KOSPI and KOSDAQ companies classified under medical supplies. Combined operating profit for the latest reported quarter across 29 of them was ₩81.8bn; 15 posted an operating loss and 1 swung to a profit from a loss a year earlier. The largest by quarterly operating profit were PharmaResearch, T&L and Seegene. The median operating margin across the 27 with reported revenue was 1.2%. 8 paid a cash dividend, with an average reported yield of 2.4%.

Medical supplies companies

Company	Latest quarter op. profit	Dividend yield	Articles 30d	Signals
PharmaResearch KOSDAQ	₩66.5bn +19% YoY	0.9%	82	Revenue & profit growth Op. margin 20%+ Dividend grower
T&L KOSDAQ	₩25.0bn +150% YoY	3.1%	1	Profit +50% Revenue +30% Revenue & profit growth Op. margin 20%+ Dividend grower
Seegene KOSDAQ	₩21.6bn +586% YoY	4.1%	5	Profit +50% Revenue & profit growth
BioNote KOSPI	₩8.5bn +33% YoY	3.8%	0	Revenue & profit growth Op. margin 20%+
Boditech Med KOSDAQ	₩8.2bn -10% YoY	–	1	–
Metabiomed KOSDAQ	₩6.3bn -20% YoY	2.1%	3	Op. margin 20%+ Dividend grower
Sewoonmedical KOSDAQ	₩3.4bn +41% YoY	–	0	Revenue & profit growth
Wonbiogen KOSDAQ	₩2.8bn +47% YoY	2.2%	2	Op. margin 20%+ Dividend grower
Jetema KOSDAQ	₩2.3bn +30% YoY	–	2	Share pledge Insider buying Insider selling Major holder adding
Bioneer KOSDAQ	₩1.2bn -78% YoY	–	4	–
GC Medical Science KOSDAQ	₩743m -30% YoY	–	0	–
ISU Abxis KOSDAQ	₩479m -95% YoY	–	10	–
SCL Science KOSDAQ	₩406m	–	22	Turnaround Insider buying Supply contract
Nibec KOSDAQ	₩103m -99% YoY	–	5	–
Access Bio KOSDAQ	−₩16m	–	0	4 quarters of losses
HLB Panagene KOSDAQ	−₩158m	–	24	4 quarters of losses
Optipharm KOSDAQ	−₩206m	–	0	Insider buying 4 quarters of losses
Celestra KOSDAQ	−₩447m	–	0	4 quarters of losses
Hass KOSDAQ	−₩615m	0.8%	0	Swung to loss Dividend cut
Gencurix KOSDAQ	−₩702m	–	19	Insider buying Delisting / halt risk M&A / stake deal 4 quarters of losses
PeopleBio KOSDAQ	−₩749m	–	2	Split / consolidation 4 quarters of losses
Asta KOSDAQ	−₩839m	–	4	Swung to loss Control change 4 quarters of losses
Humasis KOSDAQ	−₩3.3bn	–	0	Insider buying Major holder adding 4 quarters of losses
Sugentech KOSDAQ	−₩4.2bn	–	2	4 quarters of losses
Korea Arlico Pharm KOSDAQ	−₩4.6bn -375% YoY	1.7%	3	Swung to loss
AbClon KOSDAQ	−₩6.3bn	–	8	Supply contract 4 quarters of losses
HLB Life Science KOSDAQ	−₩7.6bn	–	4	4 quarters of losses
Rokit Healthcare KOSDAQ	−₩13.5bn	–	14	Swung to loss
HLB KOSDAQ	−₩22.5bn	–	92	Revenue +30% 4 quarters of losses
Hans Biomed KOSDAQ	–	–	14	–
PCL KOSDAQ	–	–	2	–
Imgt KONEX	–	–	0	–

Industry codes are the primary business each company registered with DART and may not reflect its full business mix. Figures come from DART filings; prices are not included. Not investment advice.